Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

9.190
-0.330-3.47%
Volume:135.37M
Turnover:1.24B
Market Cap:105.89B
PE:27.05
High:9.510
Open:9.510
Low:9.015
Close:9.520
52wk High:11.203
52wk Low:6.387
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:1.02
T/O Rate:1.17%
Dividend:0.30
Dividend Rate:3.31%
EPS(LYR):0.340
ROE:20.90%
ROA:10.70%
PB:2.41
PE(LYR):27.05
PS:2.90

Loading ...

CSPC Pharma Receives $25 Million R&D Milestone Payment from AstraZeneca Under Strategic Collaboration and Licensing Deal

Stock News
·
Jul 10

CSPC Pharma Receives USD 25 Million R&D Milestone Payment from Astrazeneca Under Collaboration Deal

Reuters
·
Jul 10

CSPC Pharmaceutical Group Stock Rises 3.4% in Hong Kong

Dow Jones
·
Jul 10

Bank of America Securities Foresees Valuation Re-rating for Chinese Pharma Sector Driven by Active Licensing Deals, Raises Innovent Bio Target to HK$119.2

Stock News
·
Jul 10

Movement Alert|CSPC Pharmaceutical Rises 3.19% in Regular Trading, Pharmaceutical Sector Strengthens Amid Dense Positive Catalysts

Market Focus
·
Jul 10

Investment Manager Reduces Stake in CSPC PHARMA, Selling Shares at HK$8 Each

Stock News
·
Jul 09

Dow Jones Top Company Headlines at 7 am ET: Apple to Spend $30 Billion on U.s.-made Chips from Broadcom | Trump-backed ...

Dow Jones
·
Jul 08

CSPC Pharmaceutical Group initiates Phase II trial for ANGPTL3-targeting SYH2070 Injection in mixed hyperlipidaemia

Bulletin Express
·
Jul 07

CSPC Pharma Initiates Phase II Trial in China for SYH2070 Injection in Mixed Hyperlipidemia

Stock News
·
Jul 07

CSPC Pharmaceutical Initiates Phase II China Trial of Syh2070 Injection for Mixed Hyperlipidaemia

Reuters
·
Jul 07

Movement Alert|CSPC Pharmaceutical Declines 3.28% in Regular Trading, Trading at HK$8.04

Market Focus
·
Jul 07

CSPC Pharmaceutical Group (SEHK:1093) Expands AstraZeneca Ties, Is The Upside Already Priced In?

Simply Wall St.
·
Jul 07

CSPC Pharmaceutical Group Stock Rises 2.9% in Hong Kong, Underperforms Competitors

Dow Jones
·
Jul 06

Innovative Drug Sector Maintains Upward Momentum on Favorable Regulatory Developments and Accelerating Internationalization

Stock News
·
Jul 06

Movement Alert|CSPC Pharmaceutical Rises 3.37% in Regular Trading, AstraZeneca Strategic Collaboration Worth Up to $1.77 Billion Continues to Boost Sentiment

Market Focus
·
Jul 06

CSPC Pharmaceutical Group Stock Advances 6.0% in Hong Kong, Outperforms Competitors

Dow Jones
·
Jul 03

CSPC Pharma Shares Surge Nearly 7% at Open on New $1.77 Billion Collaboration with AstraZeneca

Deep News
·
Jul 03

Movement Alert|CSPC Pharmaceutical Rises 3.31% in Regular Trading, AstraZeneca Strategic Partnership and Multiple Pipeline Milestones Fuel Sentiment

Market Focus
·
Jul 03

Uk's FTSE 100 Clinches over Two-month High on Cooling Fed Rate Hike Expectations

Reuters
·
Jul 03

CSPC Pharmaceutical Says Iron Sucrose Injection Receives Marketing Approval in China

Reuters
·
Jul 02